Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001558370-21-007266
Filing Date
2021-05-14
Accepted
2021-05-14 16:07:24
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 nrbo-20210514xs3.htm S-3 427905
2 EX-4.6 nrbo-20210514xex4d6.htm EX-4.6 442602
3 EX-4.8 nrbo-20210514xex4d8.htm EX-4.8 177230
4 EX-4.9 nrbo-20210514xex4d9.htm EX-4.9 180596
5 EX-4.10 nrbo-20210514xex4d10.htm EX-4.10 163248
6 EX-5.1 nrbo-20210514xex5d1.htm EX-5.1 59853
7 EX-23.1 nrbo-20210514xex23d1.htm EX-23.1 5003
8 GRAPHIC nrbo-20210514xex5d1001.jpg GRAPHIC 4119
9 GRAPHIC nrbo-20210514xs3006.jpg GRAPHIC 6572
  Complete submission text file 0001558370-21-007266.txt   1472562
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-256135 | Film No.: 21924595
SIC: 2834 Pharmaceutical Preparations